Literature DB >> 27345634

Tasquinimod treatment for prostate cancer.

Vicki Brower.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27345634     DOI: 10.1016/S1470-2045(16)30272-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.

Authors:  C Alberti
Journal:  G Chir       Date:  2017 Sep-Oct

2.  Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice.

Authors:  Fengchen Shen; Xiying Hou; Tingting Li; Jianjun Yu; Huizhen Chen; Na Liu; Andong Qiu; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.